Subclinical deterioration of left ventricular function in patients with juvenile-onset systemic lupus erythematosus

H-T Chung1, Y-L Huang2, K-W Yeh3

  • 1Division of Cardiology, Department of Pediatrics, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan.

Lupus
|October 11, 2014
PubMed

Insights

Systemic lupus erythematosus (SLE) in children and adolescents can lead to declining heart diastolic function over time, even without symptoms. Abnormal microvasculature, proteinuria, and longer disease duration are key risk factors for this worsening cardiac function in juvenile SLE patients.

Area of Science:

  • Cardiology
  • Rheumatology
  • Pediatrics

Background:

  • Systemic lupus erythematosus (SLE) increases the risk of myocardial involvement and ventricular dysfunction.
  • Long-term cardiac effects of juvenile-onset SLE are not well understood.
  • This study investigates chronic changes in heart function in pediatric SLE patients.

Purpose of the Study:

  • To assess long-term changes in left ventricular function in children and adolescents with juvenile-onset SLE.
  • To identify risk factors associated with cardiac dysfunction in this population.

Main Methods:

  • Longitudinal study of 92 patients with juvenile-onset SLE.
  • Two-dimensional echocardiography performed at baseline and six-month intervals.
  • Analysis included clinical parameters, disease activity, nailfold capillaroscopy, and atherosclerosis risk factors; compared with 50 age-matched controls.

Main Results:

  • Left ventricular ejection fraction (LVEF) remained stable and similar to controls.
  • The E/A ratio, indicating diastolic filling, was lower in SLE patients and decreased significantly over time.
  • Abnormal nailfold microvasculature, longer disease duration, and proteinuria were associated with worsening diastolic function.

Conclusions:

  • Juvenile-onset SLE patients exhibit declining ventricular diastolic function over time, despite normal LVEF and absence of cardiac symptoms.
  • Abnormal nailfold microvasculature, proteinuria, and extended disease duration are significant risk factors for impaired ventricular function.
  • Early monitoring of cardiac function, particularly diastolic parameters, is crucial in pediatric SLE management.
Abstract

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.2K
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
903
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.4K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
789
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
766
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
987